These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12165182)

  • 1. Kava tonga.
    Vallance AK
    J Altern Complement Med; 2002 Jun; 8(3):231-5. PubMed ID: 12165182
    [No Abstract]   [Full Text] [Related]  

  • 2. Kava (Piper methysticum).
    J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
    [No Abstract]   [Full Text] [Related]  

  • 3. Traditional use of sakau (kava) in Pohnpei: lessons for integrative medicine.
    Balick MJ; Lee R
    Altern Ther Health Med; 2002; 8(4):96-8. PubMed ID: 12126179
    [No Abstract]   [Full Text] [Related]  

  • 4. Kava-kava extract in anxiety disorders: an outpatient observational study.
    Scherer J
    Adv Ther; 1998; 15(4):261-9. PubMed ID: 10186945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kava.
    Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
    [No Abstract]   [Full Text] [Related]  

  • 6. Kava kava in the treatment of generalized anxiety disorder, simple phobia and specific social phobia.
    Boerner RJ
    Phytother Res; 2001 Nov; 15(7):646-7. PubMed ID: 11746854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kava-kava preparations--alternative anxiolytics].
    Nowakowska E; Ostrowicz A; Chodera A
    Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of panic disorders. Kava-specific extract WS 1490 compared to benzodiazepines].
    Nervenarzt; 1994 Jan; 65(1 Suppl):1-4. PubMed ID: 9218056
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S; Loew D; Gaus W
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP; Kieser M
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kava treatment in patients with anxiety.
    Geier FP; Konstantinowicz T
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
    Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-the-counter psychotropics: a review of melatonin, St John's wort, valerian, and kava-kava.
    Heiligenstein E; Guenther G
    J Am Coll Health; 1998 May; 46(6):271-6. PubMed ID: 9609974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The health and social effects of drinking water-based infusions of kava: a review of the evidence.
    Rychetnik L; Madronio CM
    Drug Alcohol Rev; 2011 Jan; 30(1):74-83. PubMed ID: 21219501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Piper methysticum (kava) under discussion: observations on quality, effectiveness and safety].
    Schmidt M; Nahrstedt A; Lüpke NP
    Wien Med Wochenschr; 2002; 152(15-16):382-8. PubMed ID: 12244883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.